Accéder au contenu
Merck
  • WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo.

WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo.

PloS one (2013-08-13)
Caihua Xu, Chen Wu, Yang Xia, Zhaopeng Zhong, Xiang Liu, Jing Xu, Fei Cui, Bin Chen, Oluf Dimitri Røe, Aihong Li, Yijiang Chen
RÉSUMÉ

The Wilms' tumor suppressor gene (WT1) has been identified as an oncogene in many malignant diseases such as leukaemia, breast cancer, mesothelioma and lung cancer. However, the role of WT1 in non-small-cell lung cancer (NSCLC) carcinogenesis remains unclear. In this study, we compared WT1 mRNA levels in NSCLC tissues with paired corresponding adjacent tissues and identified significantly higher expression in NSCLC specimens. Cell proliferation of three NSCLC cell lines positively correlated with WT1 expression; moreover, these associations were identified in both cell lines and a xenograft mouse model. Furthermore, we demonstrated that up-regulation of Cyclin D1 and the phosphorylated retinoblastoma protein (p-pRb) was mechanistically related to WT1 accelerating cells to S-phase. In conclusion, our findings demonstrated that WT1 is an oncogene and promotes NSCLC cell proliferation by up-regulating Cyclin D1 and p-pRb expression.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-WT1 Antibody, clone 6F-H2, clone 6F-H2, Upstate®, from mouse